Michael Oredsson is stepping down as chief executive of BioInvent International AB at the end of the year, declaring that the Swedish biotech should be now led with a more scientific background.
Oredsson has been at the helm for four years but both he and the board say they believe "it is...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?